Description
Product details
Encicarb Injection is an intravenous iron preparation containing Ferric Carboxymaltose. It is used for the management of iron deficiency anaemia (IDA) when the body does not have enough available iron to produce healthy red blood cells. Adequate iron is essential for haemoglobin formation and oxygen transport. When iron levels become too low, symptoms such as fatigue, weakness, dizziness and reduced energy may occur. Encicarb provides iron directly through intravenous administration to help replenish iron stores under medical supervision. Key Benefits Helps replenish depleted iron stores Supports haemoglobin and red blood cell production Used in the management of iron deficiency anaemia May help improve symptoms associated with iron deficiency, such as weakness and tiredness Provides an intravenous iron option when clinically recommended How Encicarb Injection Is Given Encicarb Injection should be administered only by a doctor, nurse or trained healthcare professional. The required dose and treatment schedule are determined according to the patient's iron status, haemoglobin level, body weight and clinical condition. Do not self-administer this injection. Possible Side Effects Some patients may experience: Nausea Vomiting Headache Dizziness Increased blood pressure Injection-site pain, redness or swelling Changes in stool colour Seek medical advice if any reaction persists, becomes severe or causes concern. Important Precautions Before receiving Encicarb, inform your healthcare professional about existing medical conditions, previous reactions to injectable iron preparations and medicines currently being used. Iron status and haemoglobin may be monitored during treatment.
